Preece Pharma Consultancy Limited 15721888 false 2024-05-15 2025-05-31 2025-05-31 The principal activity of the company is other business activities not elsewhere classified. Digita Accounts Production Advanced 6.30.9574.0 true 15721888 2024-05-15 2025-05-31 15721888 2025-05-31 15721888 bus:Director1 1 2025-05-31 15721888 bus:Director2 1 2025-05-31 15721888 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 15721888 bus:Micro-entities 2024-05-15 2025-05-31 15721888 bus:AuditExemptWithAccountantsReport 2024-05-15 2025-05-31 15721888 bus:FullAccounts 2024-05-15 2025-05-31 15721888 bus:SmallCompaniesRegimeForAccounts 2024-05-15 2025-05-31 15721888 bus:RegisteredOffice 2024-05-15 2025-05-31 15721888 bus:Director1 2024-05-15 2025-05-31 15721888 bus:Director1 1 2024-05-15 2025-05-31 15721888 bus:Director2 2024-05-15 2025-05-31 15721888 bus:Director2 1 2024-05-15 2025-05-31 15721888 bus:PrivateLimitedCompanyLtd 2024-05-15 2025-05-31 15721888 countries:AllCountries 2024-05-15 2025-05-31 15721888 bus:Director1 1 2024-05-14 15721888 bus:Director2 1 2024-05-14 iso4217:GBP xbrli:pure

Registration number: 15721888

Preece Pharma Consultancy Limited
Annual Report and Unaudited Financial Statements
for the Period from 15 May 2024 to 31 May 2025

Preece Pharma Consultancy Limited

Contents

Company Information | 1
Balance Sheet | 2 to 4
Notes to the Unaudited Financial Statements | 3

Preece Pharma Consultancy Limited

Company Information

Directors | D J Preece LP Preece

Registered office | Suite A4, Skylon Court Coldnose Road Rotherwas Hereford HR2 6JS

Accountants | Boon and Worth Limited Suite A4, Skylon Court Coldnose Road Rotherwas Hereford HR2 6JS

Preece Pharma Consultancy Limited

(Registration number: 15721888)
Balance Sheet as at 31 May 2025

| 2025 £
Current assets | 9,119
Creditors: Amounts falling due within one year | (2,698)
Total assets less current liabilities | 6,421
Accruals and deferred income | (1,800)
| 4,621
Capital and reserves | 4,621

Preece Pharma Consultancy Limited

(Registration number: 15721888)
Balance Sheet as at 31 May 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales..

The address of its registered office is:
Suite A4, Skylon Court
Coldnose Road
Rotherwas
Hereford
HR2 6JS
England

These financial statements were authorised for issue by the Board on 19 November 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2 | Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

3 | Related party transactions

Transactions with directors

2025 | At 15 May 2024 £ | Advances to director £ | Repayments by director £ | At 31 May 2025 £
D J Preece
Directors loan account | - | 901 | (1,106) | (205)
LP Preece
Directors loan account | - | 1 | (1,106) | (1,105)

Preece Pharma Consultancy Limited

(Registration number: 15721888)
Balance Sheet as at 31 May 2025

For the financial period ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 19 November 2025 and signed on its behalf by:

......................................... D J Preece Director
......................................... LP Preece Director